These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38390699)

  • 41. Cytopathological Features of
    Takeda M; Tani Y; Saijo N; Shimizu S; Taniguchi Y; Otsuka K; Nakao K; Tamiya A; Okishio K; Atagi S; Ohbayashi C; Kasai T
    Int J Surg Pathol; 2020 Feb; 28(1):109-114. PubMed ID: 31448657
    [No Abstract]   [Full Text] [Related]  

  • 42. Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications.
    Leckey BD; Selim MA; Al-Rohil RN
    J Cutan Pathol; 2020 Jun; 47(6):561-565. PubMed ID: 31995235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
    Matsushita M; Kuwamoto S
    Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors.
    Luo J; Ding B; Campisi A; Chen T; Teng H; Ji C
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4455-4463. PubMed ID: 36121510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma].
    Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
    Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expanding the Immunophenotype Spectrum of SMARCA4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression.
    Mao R; Liu M; Shu X; Li W; Yan W; Li X
    Int J Surg Pathol; 2022 May; 30(3):251-259. PubMed ID: 34633874
    [No Abstract]   [Full Text] [Related]  

  • 47. SMARCA4-Deficient Undifferentiated Tumor Diagnosed on Adrenal Sampling.
    Ashour S; Reynolds JP; Mukhopadhyay S; McKenney JK
    Am J Clin Pathol; 2022 Jan; 157(1):140-145. PubMed ID: 34463317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor.
    Shinno Y; Yoshida A; Masuda K; Matsumoto Y; Okuma Y; Yoshida T; Goto Y; Horinouchi H; Yamamoto N; Yatabe Y; Ohe Y
    Clin Lung Cancer; 2022 Jul; 23(5):386-392. PubMed ID: 35618627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.
    Kunimasa K; Nakamura H; Sakai K; Tamiya M; Kimura M; Inoue T; Nishino K; Kuhara H; Nakatsuka SI; Nishio K; Imamura F; Kumagai T
    Lung Cancer; 2019 Jun; 132():59-64. PubMed ID: 31097095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation association.
    Lin DI; Allen JM; Hecht JL; Killian JK; Ngo NT; Edgerly C; Severson EA; Ali SM; Erlich RL; Ramkissoon SH; Vergilio JA; Ross JS; Elvin JA
    Mod Pathol; 2019 Nov; 32(11):1675-1687. PubMed ID: 31190001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SMARCA4-deficient thoracic sarcoma revealed by metastasis to the small intestine: a diagnostic dilemma.
    Khanchel F; Hedhili R; Zenaidi H; Helal I; Yahmadi A; Ben Néji H; Ksontini F; Ben Brahim E; Jouini R; Chadli A
    Gen Thorac Cardiovasc Surg; 2021 Jul; 69(7):1155-1158. PubMed ID: 33866513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors.
    Wang J; Elghawy O; Kurpiel B; Kaur V
    Clin J Gastroenterol; 2023 Dec; 16(6):807-814. PubMed ID: 37651059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].
    Wang XT; Kang Y; Wang HY; Shi WW; Xiao Y; Liu YH; Si JM; Li SL; Jin JJ
    Zhonghua Yi Xue Za Zhi; 2024 Sep; 104(34):3214-3220. PubMed ID: 39193606
    [No Abstract]   [Full Text] [Related]  

  • 54. SWI/SNF-deficient thoraco-pulmonary neoplasms.
    Sesboue C; Le Loarer F
    Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
    Kawachi H; Kunimasa K; Kukita Y; Nakamura H; Honma K; Kawamura T; Inoue T; Tamiya M; Kuhara H; Nishino K; Mizote Y; Akazawa T; Tahara H; Kumagai T
    Immunotherapy; 2021 Jul; 13(10):799-806. PubMed ID: 34030451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.
    Le Loarer F; Watson S; Pierron G; de Montpreville VT; Ballet S; Firmin N; Auguste A; Pissaloux D; Boyault S; Paindavoine S; Dechelotte PJ; Besse B; Vignaud JM; Brevet M; Fadel E; Richer W; Treilleux I; Masliah-Planchon J; Devouassoux-Shisheboran M; Zalcman G; Allory Y; Bourdeaut F; Thivolet-Bejui F; Ranchere-Vince D; Girard N; Lantuejoul S; Galateau-Sallé F; Coindre JM; Leary A; Delattre O; Blay JY; Tirode F
    Nat Genet; 2015 Oct; 47(10):1200-5. PubMed ID: 26343384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delayed Diagnosis of SMARCA4-Deficient Undifferentiated Tumor in a Heavy Smoker Male Patient: Discovered Through Bone Sampling, with Extensive Distant Metastases and Concurrent Granulomatous Disease, Leading to Patient Fatality.
    Shaker N; Ben Musa R; Tynski Z; Shaker N; Sangueza OP; Boyd B
    Int J Surg Pathol; 2024 Jun; ():10668969241260215. PubMed ID: 38899907
    [No Abstract]   [Full Text] [Related]  

  • 58. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
    Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
    Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thoracic SMARCA4-deficient undifferentiated tumors mimicking inflammatory lesions.
    Ma P; Cheng A; Song F; Sun Y
    Asian J Surg; 2024 May; 47(5):2290-2291. PubMed ID: 38331614
    [No Abstract]   [Full Text] [Related]  

  • 60. The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
    Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.